N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide
C27H40N4O2 — CID 157057404
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide
N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide (PubChem CID 157057404) has the molecular formula C27H40N4O2 and a molecular weight of 452.64 g/mol. Its IUPAC name is N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide.
Molecular Properties
| Compound Name | N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide |
|---|---|
| PubChem CID | 157057404 |
| Molecular Formula | C27H40N4O2 |
| Molecular Weight | 452.64 g/mol |
| Exact Mass | 452.32 |
| IUPAC Name | N-[3-[4-cyclopropyl-5-(4-methylpentyl)-1,2,4-triazol-3-yl]-6-(2,4-dimethylphenyl)-5-oxohexyl]acetamide |
| SMILES | CC(=O)NCCC(CC(=O)Cc1ccc(C)cc1C)c1nnc(CCCC(C)C)n1C1CC1 |
| InChI | InChI=1S/C27H40N4O2/c1-18(2)7-6-8-26-29-30-27(31(26)24-11-12-24)23(13-14-28-21(5)32)17-25(33)16-22-10-9-19(3)15-20(22)4/h9-10,15,18,23-24H,6-8,11-14,16-17H2,1-5H3,(H,28,32) |
| InChIKey | AAXPATDGLRCQOI-UHFFFAOYSA-N |
| XLogP | 5.02 |
| TPSA | 76.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.64 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157057404 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.